Peptide Therapeutics Market Share

Statistics for the 2023 & 2024 Peptide Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Peptide Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Peptide Therapeutics Industry

The peptide therapeutics market is highly competitive and fragmented, consisting of several major players. Some of the companies currently dominating the market are Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, Novo Nordisk AS, Novartis AG, Zealand Pharma AG, and SELLAS Life Sciences Group (Galena Biopharmaceuticals).

Peptide Therapeutics Market Leaders

  1. Eli Lilly and Company

  2. Amgen Inc.

  3. Bristol-Myers Squibb Company

  4. GlaxoSmithKline PLC

  5. AstraZeneca PLC

*Disclaimer: Major Players sorted in no particular order

Peptide Therapeutics Market  Concentration

Peptide Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)